Top U.S. companies honored for their excellence in combating antisemitism and hate, support for Israel, and efforts that align with Tikkun Olam principles
New York, NY, April 10, 2025 – JLens, a Registered Investment Advisor (RIA) and affiliate of ADL (the Anti-Defamation League), announced today the recipients of its 2024 Corporate TOV Awards. The TOV Awards, whose name reflects the Hebrew word for “good,” were created to annually recognize and honor 18 companies that rank highly and outperform peer companies according to JLens’ Jewish values scorecards.
The 18 TOV Awards recipients were selected based on JLens’ proprietary scorecards, which measure the companies’ performance in Combating Antisemitism & Hate, Support for Israel, and Tikkun Olam (Repairing the World). In Jewish culture, the number 18 is significant because it is the numerical value of the letters in the Hebrew word "chai," which means "life." To be eligible, companies must be included in the JLens 500 Jewish Advocacy U.S. Index, which is composed of most of the 500 largest U.S. public companies. The scorecards are informed by robust data collection, in-depth research, and direct engagement with companies.
“It is truly gratifying to be able to recognize the positive contributions of major U.S. corporations in supporting Jewish values, especially at a time of rising antisemitic activity, aggressive anti-Israel campaigns, and a pervasive atmosphere of intolerance,” said Jonathan A. Greenblatt, CEO and National Director of ADL. “We applaud the TOV Award recipients and hope that they will serve as role models of respect, tolerance and compassion for their peer companies.”
"JLens uniquely researches corporate behavior on issues important to the Jewish community, annually collecting over 30,000 data points on companies, and uses this analysis to guide our advocacy," said Ari Hoffnung, JLens Managing Director. "Our company scorecards inform our comprehensive shareholder advocacy approach as we combat antisemitism and anti-Israel bias through direct engagement with executives, proxy voting on directors and resolutions, filing our own shareholder resolutions when necessary, and conducting broader public advocacy campaigns."
The TOV Awards recipients are (in alphabetical order):
1. AbbVie (NYSE: ABBV)
2. Accenture (NYSE: ACN)
3. American Express (NYSE: AXP)
4. Applied Materials (NASDAQ: AMAT)
5. Bristol-Myers Squibb (NYSE: BMY)
6. Cisco (NASDAQ: CSCO)
7. Citigroup (NYSE: C)
8. Gilead Sciences (NASDAQ: GILD)
9. International Business Machines (NYSE: IBM)
10. Intuit (NASDAQ: INTU)
11. Johnson & Johnson (NYSE: JNJ)
12. Marriott International (NASDAQ: MAR)
13. Mastercard (NYSE: MA)
14. Medtronic (NYSE: MDT)
15. Merck & Co (NYSE: MRK)
16. Microsoft (NASDAQ: MSFT)
17. Oracle (NYSE: ORCL)
18. Salesforce (NYSE: CRM)
More information on each of these recipients and on these awards can be found on the JLens’ website, jlensnetwork.org.
The 18 corporations receiving the JLens Corporate TOV Award operate in Israel or have significant relationships and direct investments in the Israeli economy. Many of these companies have shown significant support for their Israeli and Jewish employees following October 7, 2023 and have religious inclusion initiatives in place, including initiatives that can support the inclusion of Jewish employees. Additionally, these companies also have strong performance in JLens’ Tikkun Olam scorecard.
“The Applied Materials team is proud to receive the JLens 2024 Corporate TOV Award. At Applied, we push the boundaries of materials science and engineering to create next-generation technology. By building a workplace where everyone shares their best ideas, we can work together to advance the world’s technology,” said Liz Morali, Vice President of Investor Relations, Applied Materials.
"Merck is honored to receive the JLens 2024 Corporate TOV Award. This recognition reflects our dedication to operating responsibly every day to enable a safe, sustainable and healthy future for people and communities everywhere," said Celeste Warren, Vice President and Head of Global Diversity and Inclusion at Merck.
JLens is the Fund Sponsor of the JLens 500 Jewish Advocacy U.S. ETF (NYSE:TOV), a unique exchange-traded fund that recently launched on the New York Stock Exchange. The TOV ETF was launched by JLens and ADL as an additional tool to combat the dramatic spike in antisemitism following the Hamas attack on Israel on October 7, 2023, and particularly the wave of actions against corporations by the Boycott, Divest and Sanctions (BDS) movement, as well as increasing hostility toward Jewish employees in some workplaces. TOV uses its position as a shareholder in major U.S. public companies to advocate for Jewish communal interests through engagement with management and boards of directors, proxy voting, and other forms of shareholder advocacy. As of [date] the ETF’s assets under management exceeded $100 million.
About JLens
Founded in 2012, JLens is a 501(c)(3) nonprofit and Registered Investment Advisor that empowers investors to align their capital with Jewish values and advocates for Jewish communal priorities in the corporate arena. JLens’ Jewish Investor Network is composed of over 30 Jewish institutions, representing $11 billion in communal capital. In 2022, JLens established an affiliation with ADL (Anti-Defamation League), the leading anti-hate organization in the world. More at www.jlensnetwork.org.
About ADL
ADL is the leading anti-hate organization in the world. Founded in 1913, its timeless mission is “to stop the defamation of the Jewish people and to secure justice and fair treatment to all.” Today, ADL continues to fight all forms of antisemitism and bias, using innovation and partnerships to drive impact. A global leader in combating antisemitism, countering extremism and battling bigotry wherever and whenever it happens, ADL works to protect democracy and ensure a just and inclusive society for all. More at www.adl.org.
The fund's investment objectives, risks, charges and expenses must be considered carefully before investing. The Prospectus and SAI contains this and other important information about the investment company, and it may be obtained by calling (215) 330-4476. Read it carefully before investing.
ADL and JLens are affiliated nonprofit organizations. Neither organization's staff receive direct or indirect compensation for referrals or purchases of TOV ETF or any other investment products. This communication is informational and does not constitute a securities offer.
Investing involves risk. Principal loss is possible. The Index considers JLens’ Jewish Value Pillars in its index methodology and may exclude otherwise profitable investments in companies which have been identified as being in conflict with JLens’ Jewish Value Pillars. The Fund is not actively managed, and the Adviser will not sell any investments due to current or projected underperformance of the securities, industries or sector in which it invests, unless the investment is removed from the Index, sold in connection with a rebalancing of the Index as addressed in the Index methodology, or sold to comply with the Fund’s investment limitations.
Large-Capitalization Companies Risk: Large- capitalization companies may trail the returns of the overall stock market. Large capitalization stocks tend to go through cycles of doing better – or worse – than the stock market in general. These periods have, in the past, lasted for as long as several years. When large capitalization companies are out of favor, these securities may lose value or may not appreciate in line with the overall market. In addition, large capitalization companies may be unable to respond quickly to new competitive challenges, such as changes in technology or consumer tastes, and also may not be able to attain the high growth rate of successful small companies, especially during extended periods of economic expansion.
Jewish Values Investing Risk: The Index considers JLens’ Jewish Value Pillars.
The JLens 500 Jewish Advocacy U.S. ETF is distributed by Quasar Distributors, LLC.